N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)-1-methyl-1H-indole-6-carboxamide

ID: ALA2402003

PubChem CID: 58328191

Max Phase: Preclinical

Molecular Formula: C21H21N3O2

Molecular Weight: 347.42

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2ccn(C)c2c1

Standard InChI:  InChI=1S/C21H21N3O2/c1-13-3-4-15(20(25)22-17-7-8-17)11-18(13)23-21(26)16-6-5-14-9-10-24(2)19(14)12-16/h3-6,9-12,17H,7-8H2,1-2H3,(H,22,25)(H,23,26)

Standard InChI Key:  PUZHKYXTJMQSQI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   16.3737   -6.1091    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6573   -5.6993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9446   -6.1111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6555   -4.8732    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3700   -4.4586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0834   -4.8730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7974   -4.4591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7960   -3.6320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0747   -3.2206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3636   -3.6370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6452   -3.2289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5136   -4.8709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5150   -5.6970    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.2283   -4.4566    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.9445   -4.8684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3558   -5.5797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7675   -4.8636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2335   -5.6992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5213   -6.1104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9484   -6.9322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2391   -7.3456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5211   -6.9393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9127   -7.4966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2548   -8.2475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0745   -8.1541    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6326   -8.7632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
  7 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 16 15  1  0
 17 16  1  0
 15 17  1  0
  3 18  2  0
 18 19  1  0
 19 22  2  0
 21 20  2  0
 20  3  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 21  1  0
 25 26  1  0
M  END

Associated Targets(Human)

MAPK11 Tchem MAP kinase p38 beta (2785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.42Molecular Weight (Monoisotopic): 347.1634AlogP: 3.63#Rotatable Bonds: 4
Polar Surface Area: 63.13Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.44CX LogD: 3.44
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -1.55

References

1. Wrobleski ST, Lin S, Dhar TG, Dyckman AJ, Li T, Pitt S, Zhang R, Fan Y, Doweyko AM, Tokarski JS, Kish KF, Kiefer SE, Sack JS, Newitt JA, Witmer MR, McKinnon M, Barrish JC, Dodd JH, Schieven GL, Leftheris K..  (2013)  The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode.,  23  (14): [PMID:23746475] [10.1016/j.bmcl.2013.05.047]

Source